Interestingly, gene expression profiling showed that 54% of HGBL, NOS harbour the “double hit” signature (DHITsig) characteristic of LBCL/HGBL with MYC/BCL2 despite lacking rearrangements of these genes [144]. The gene discussed is MYC; the disease is high grade B-cell lymphoma.